"Doubling as an Ophthalmologist office and alternative art gallery, Comprehensive Eye Care provides an appealing and spacious facility catered toward the health and comfort of each patient. Serving Franklin County, MO, Drs. Michael Korenfeld, MD, ACOS, and Matthew Lazarus, OD offer their ever-growing expertise in all areas of eye care. Patients of all ages are provided individualized care beginning with flexible scheduling and hours. From routine eye exams, to contact lenses, along with our extensive line of frames, patients are provided convenient and quality eye care. Where most Ophthalmology offices have a waiting list for appointments, Comprehensive Eye Care works with each patient’s schedule, avoiding week or month-long wait times."

During the past decade, Comprehensive Eye Care Ltd. conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 17 clinical trials were completed, i.e. on average, 81% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 11 clinical trials were completed. i.e. 220% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Comprehensive Eye Care Ltd." #1 sponsor was "Allergan" with 5 trials, followed by "Kala Pharmaceuticals, Inc." with 3 trials sponsored, "EyeKon Medical, Inc." with 2 trials sponsored, "Eyegate Pharmaceuticals, Inc." with 2 trials sponsored and "Mati Therapeutics Inc." with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Eye Care Ltd." #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Bausch & Lomb Incorporated" with 1 trials as a collaborator, "ORA, Inc." with 1 trials as a collaborator, "River Plate Biotechnology, Inc." with 1 trials as a collaborator and "Rx Development Resources, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Eye Care Ltd." are "Dry Eye Syndromes" (5 trials), "Dry Eye Disease" (3 trials), "Keratoconjunctivitis Sicca" (3 trials), "Blepharitis" (2 trials) and "Blepharoptosis" (2 trials). Many other conditions were trialed in "Comprehensive Eye Care Ltd." in a lesser frequency.

Most popular intervention types in "Comprehensive Eye Care Ltd." are "Drug" (31 trials), "Device" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Vehicle" (5 trials), "DE-117 Ophthalmic Solution" (2 trials), "Difluprednate" (2 trials) and "RVL-1201" (2 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Eye Care Ltd." are 35 trials for "All" genders.

Currently, there are NaN active trials in "Comprehensive Eye Care Ltd.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Comprehensive Eye Care Ltd., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Eye Care Ltd., 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".